--- Chain 2 for Question 102 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: D
Prompt Tokens (Usage): 439
Completion Tokens (Usage): 4794
Reasoning Tokens (Counted): 4204
Non-Reasoning Tokens (Counted): 588
Total Tokens (Usage): N/A

--- Reasoning Content ---
Okay, let's try to work through this problem. Hmm, the question is about a genetic construct and why there's no green signal observed in the offspring. I remember that in biotechnology, constructs like these often involve fluorescent markers to track expression. So the setup here is a bicistronic vector, which means it has two genes under a single promoter. 

Alright, the vector has a ligand ORF at the 5' end fused to mCherry, and the receptor ORF at the 3' end with eGFP at the C-terminus. Wait, but each of these is separated by stop cassettes with loxP and lox2272 sites. Oh, right, these are different lox sites for Cre recombinase. So when Cre is present, it can excise the stop cassette, allowing the downstream gene to be expressed.

The ligand is under the CBA promoter, which I think is a strong promoter, maybe constitutive. The receptor is under an IRES element. IRES allows for internal ribosome entry, so the receptor should be expressed as a separate transcript, but only if the IRES is functional. Wait, but the vector is bicistronic, meaning the same transcript has both ORFs. So maybe the CBA promoter drives the transcription of both ligand and receptor, with the IRES allowing the receptor to be translated after the ligand.

But then the stop cassettes complicate things. Between ligand and mCherry is a loxP-stop-loxP. So normally, without Cre, the ligand would be expressed, and the stop would prevent mCherry from being expressed. But wait, the ligand is fused to mCherry. Oh, wait, perhaps the construct is such that the ligand is in-frame with mCherry, but the stop cassette prevents co-expression. Or maybe the stop cassette is just preventing the second gene from being expressed unless Cre is present. Hmm, I'm getting a bit confused.

The antibodies were raised against the overexpressed proteins. They tested the construct expression on Western blot after transfecting into primary astrocytes. The blot shows signals proportional to actin, which is a loading control. So they probably are seeing expression of the ligand and receptor proteins. But then, in the mouse model, when they breed the homozygous construct mice with SOX10-Cre mice, they don't see the green signal.

Wait, SOX10 is a transcription factor involved in neural crest development. SOX10-Cre would express Cre under the control of SOX10 regulatory elements, meaning Cre is active in neural crest-derived cells. So when the Cre is present, it would recombine the lox sites.

Looking at the construct: the ligand is at 5', with a stop cassette (loxP) followed by mCherry. The receptor is at 3', preceded by an IRES and a lox2272 stop cassette. So when Cre is present, which lox sites would be cut?

Ligand is under CBA promoter, so it's transcribed. The first ORF is ligand, then the loxP-stop-loxP. Cre would recognize loxP sites. So when Cre is expressed, it would excise the stop cassette between ligand and mCherry. That would allow mCherry to be expressed along with ligand.

But for the receptor, the stop cassette is between the receptor and eGFP, and it's using lox2272 sites. Wait, Cre from the loxP system (like the one in SOX10-Cre) would recognize loxP sites, but lox2272 is a variant. Oh wait, lox2272 is a different recombinase target, perhaps only recognized by a different Cre or a mutant Cre? Or maybe the same Cre can recognize both, but I'm not sure.

Wait, in the vector, the ligand is under CBA, and the receptor is under IRES. So the CBA promoter would drive the transcription, and the IRES would allow the receptor's ORF to be translated after the ligand's. So without Cre, the ligand would be expressed but not mCherry (due to loxP stop). The receptor would be expressed only if the IRES is functional, but also, the eGFP is after a lox2272 stop cassette. So without Cre, the eGFP is not expressed because the stop cassette is in place.

But when Cre is expressed, SOX10-Cre would provide Cre. So Cre would recognize the loxP sites in the ligand's stop cassette, excising it. So mCherry would be expressed along with ligand. But what about the receptor and eGFP? The stop cassette between receptor and eGFP is lox2272. Does the Cre from SOX10-Cre recognize lox2272?

Wait, I think that loxP and lox2272 are different; lox2272 is a mutant lox site that is only recognized by a Cre variant that doesn't require the wild-type loxP. Or maybe the standard Cre can't recombine lox2272. I might be getting this wrong. Alternatively, perhaps the lox2272 is used in a different system, perhaps for conditional expression without interference from wild-type Cre.

So if the mouse is homozygous for the construct and crossed with SOX10-Cre hemizygous mice, then the Cre is expressed in neural crest cells. But the Cre from SOX10-Cre might not act on the lox2272 sites.

So the ligand's stop cassette (loxP) would be excised, allowing mCherry to be expressed. The receptor's stop cassette (lox2272) wouldn't be cut because Cre can't recognize lox2272. Thus, the eGFP wouldn't be expressed.

But the question is about the green signal, which is eGFP. So if the eGFP isn't being expressed, that's why they don't see the green signal.

Looking at the options:

A) ligand and receptor are paracrine: not directly relevant to expression.

B) receptor-eGFP stuck in Golgi: possible, but the Western blot would show the protein. Also, the construct is designed to express, but if the stop wasn't removed, the protein wouldn't be made.

C) Enhancer missing: the promoters are present, so expression should occur.

D) Receptor and eGFP not in frame: If the ORF is not in frame, the eGFP wouldn't be expressed, but the Western blot would show the receptor if the frame is correct.

Wait, but in the vector, the receptor is at the 3' end, with eGFP fused. The stop cassette is between receptor and eGFP. So in the absence of Cre, the eGFP isn't expressed. If Cre can't excise the lox2272 stop, then the eGFP isn't expressed.

So the issue is that the Cre can't recombine the lox2272 sites. Therefore, the eGFP isn't expressed. So the green signal (eGFP) isn't observed.

Which option corresponds to this?

Looking at the options again:

D) The receptor and eGFP are not in frame. That would cause eGFP not to be expressed, but only if the ORF is messed up. But the construct is designed so that the stop is in the way, not the ORF. So the frame is correct.

Alternatively, perhaps the lox2272 isn't being cut, so the stop remains, so eGFP isn't expressed. So the issue is that Cre can't cut the lox2272. So which option describes this?

Well, the options don't directly address this. Let me look again. The options are:

A) ligand and receptor are in a paracrine relationship. That's about their function, not expression. Unrelated to the construct.

B) Receptor-eGFP stuck in Golgi. That would affect localization, but if the protein is expressed, you'd see it in Western. The blot is okay, I think.

C) Enhancer for ligand and receptor is missing. But they're under CBA and IRES, which should be sufficient.

D) Receptor and eGFP not in frame. If they are not in frame, the eGFP wouldn't be expressed. But why would that be? The construct is designed to have the receptor ORF followed by eGFP, but with a stop in between. So, perhaps the frame is correct, but the stop is preventing expression. So if the stop isn't removed, eGFP isn't expressed.

Wait, but the question states that they used the antibodies to test construct expression on Western blot after transfection. So the blot showed signals proportional to actin, meaning that the proteins were expressed. Wait, but the vector has the ligand and receptor each with their own fusions. So in the absence of Cre, the ligand is expressed with mCherry, but only if the stop is removed. Or is it the other way around?

Wait, perhaps the construct is a bicistronic vector, where the same transcript encodes both ligand and receptor. But only one is expressed, depending on the stop cassettes. So without Cre, ligand and mCherry are expressed, but receptor and eGFP are not, because their stop cassette is in place. Wait, no, because the ligand's stop is loxP, and the receptors' is lox2272.

Wait, maybe I'm overcomplicating. The question is about why the green signal (eGFP) isn't observed in the offspring. The problem arises after breeding with SOX10-Cre. So the Cre is active in neural crest cells, and should excise the lox sites.

Assuming that the SOX10-Cre can't recognize the lox2272 sites, the stop cassette between receptor and eGFP isn't excised. Therefore, the eGFP isn't expressed. So the mouse isn't expressing eGFP, so no green signal.

Looking at the options, the only one that points to the expression issue is D: the receptor and eGFP are not in frame. But wait, that would be a frameshift, but the construct is designed with the ORFs in frame. Alternatively, perhaps the issue is that the stop cassette isn't excised, so the eGFP isn't expressed. But the options don't directly state that.

Another thought: the IRES is supposed to allow the receptor to be expressed. If the IRES isn't functional, then the receptor isn't expressed. But the CBA promoter is strong, so perhaps the receptor is expressed.

Wait, the ligand is under CBA, the receptor is under IRES. So the same transcript is used. The IRES allows the receptor to be translated after the ligand. So the receptor is expressed, but the eGFP isn't, unless the stop is removed.

Ah, but the stop is after the receptor ORF, so without the stop being removed, the eGFP isn't expressed. So if the Cre can't remove the stop, eGFP isn't expressed.

So the problem is that the eGFP isn't being expressed because the Cre can't remove the lox2272 stop cassette.

Looking at the options again:

Option D says the receptor and eGFP are not in frame. If that were the case, then the eGFP wouldn't be expressed. But that's a design issue, not something caused by the Cre system. Alternatively, the problem is with the Cre not acting on the lox2272 sites.

But the options don't mention that. So perhaps the correct answer is D, but I'm not entirely sure. Alternatively, maybe option C is about the enhancer, but the promoters are present.

Wait, another angle: when they used the antibodies against the overexpressed proteins in Western blot, the expression was correct. So the construct works when transfected into astrocytes. So in that case, the expression is inducible with Cre. But in the mouse, when crossed with SOX10-Cre, the eGFP isn't expressed. So why?

If the vector uses loxP and lox2272, and the Cre can only recognize loxP, then the stop cassette for ligand is removed, allowing mCherry to be expressed. But the receptor's stop isn't removed (since Cre can't act on lox2272), so eGFP isn't expressed.

So the issue is that the Cre can't cut the lox2272 site, so the eGFP isn't expressed. Thus, the green signal isn't seen.

But none of the options directly state this. So looking again at the options:

Option D: receptor and eGFP not in frame. If they were out of frame, the eGFP wouldn't be expressed, but that's a design flaw. Since the construct was successfully expressed in the Western blot, perhaps the issue is the stop cassette.

Wait, but in the mouse model, the expression is in the neural crest, which is where SOX10-Cre is active. So perhaps the Cre can't remove lox2272. Therefore, the eGFP isn't expressed. So the correct answer is that the stop cassette isn't excised, perhaps because the Cre can't recognize lox2272.

But the options don't have this as a choice. So perhaps the correct answer is D, but I'm not certain. Alternatively, maybe the IRES isn't functional, but that's an 'enhancer' related issue, which is option C.

Wait, no, the IRES is a separate regulatory element. The enhancer is about the promoter region, so option C says the enhancer is missing, which would affect expression. But the CBA promoter is a strong promoter, so perhaps the issue isn't the enhancer.

Alternatively, maybe the eGFP is not being translated because of the stop cassette, but the options don't address that.

Wait, another thought: when using a bicistronic vector with two ORFs, each separated by a stop cassette, if the stop is not removed, the second ORF isn't expressed. So in this case, after the Cre is introduced, the ligand's stop is removed, allowing mCherry to be expressed, but the receptor's stop isn't removed, so eGFP isn't expressed.

So the green signal (eGFP) isn't expressed because the Cre can't remove the lox2272 stop cassette. Thus, the reason is that the eGFP isn't expressed because the stop isn't excised.

Looking at the options, option D is about the ORFs not being in frame, which would cause eGFP not to be expressed. But if the vectors were designed correctly, the ORFs should be in frame.

Hmm, perhaps the correct answer is D. But I'm not entirely confident. Alternatively, perhaps the problem is that the eGFP is not expressed because the stop isn't removed, but I don't see that option.

Wait, the question says that the offspring were visualized under a confocal microscope and no green signal was observed. So the eGFP is not expressed.

The possible reasons are:

- The eGFP is not being expressed because the stop cassette wasn't removed (so Cre didn't act on it).

- The construct didn't integrate correctly.

But the question setup says that the Western blot showed expression, so the construct is functional.

Wait, the Western blot was done after transfection into primary astrocyte culture, meaning that the construct works. So the problem must be that in the mouse model, the Cre isn't able to remove the stop cassette for the receptor-eGFP.

If the Cre can't act on the lox2272 sites, then the eGFP won't be expressed. So why would that happen? Because the Cre doesn't recognize lox2272.

But looking at the options, none directly address this. So perhaps the answer is D: the receptor and eGFP are not in frame. Because the stop cassette is in the way, regardless of frame. Alternatively, maybe the stop is not removed, so the eGFP isn't expressed.

Wait, but in the vector, the eGFP is after the stop cassette. So in the absence of Cre, the eGFP isn't expressed. But with Cre, if it can remove the stop, then eGFP is expressed.

So the issue is that the Cre can't remove the stop cassette. Therefore, the eGFP isn't expressed.

So why isn't the Cre working? Because the lox2272 isn't recognized by the Cre.

But the options don't have this. So perhaps the correct answer is D, but I'm not 100% certain.

Alternatively, perhaps the answer is C: the enhancer is missing. But the CBA promoter is a strong enhancer/promoter, so this might not be the case.

Wait, another angle: the IRES is necessary for the receptor expression. If the IRES is non-functional, the receptor wouldn't be expressed. But the same IRES would affect both ORFs, perhaps? Or is it that the ligand is under CBA and the receptor under IRES.

Hmm, perhaps the Western blot in astrocytes showed that the ligand and receptor were expressed, but in the mouse model, maybe the IRES isn't working in the specific cells (neural crest), but that's a stretch.

Alternatively, the eGFP isn't expressed because the stop isn't removed, but the options don't have that.

Wait, looking back at the options, option D says the receptor and eGFP are not in frame. If this is the case, then even if the stop cassette is removed, the eGFP wouldn't be expressed because the ORF is disrupted. But I think that the construct would have them in frame to allow expression.

Hmm. Perhaps the correct answer is D. Alternatively, maybe option B is correct.

Wait, option B says the receptor-eGFP is stuck in the Golgi. If the protein isn't transported out, it wouldn't fluoresce. But if the protein is expressed, the Western blot would detect it. Since the blot showed proper expression, this might not be the case.

Alternatively, maybe the eGFP is expressed but not functional. But the question is about the green signal, which depends on eGFP being expressed and fluorescent.

I think the most plausible answer is that the Cre isn't able to remove the lox2272 stop cassette, so the eGFP isn't expressed. But the options don't include that, so I might have to choose the next best fit.

Wait, another possibility: the vector's design. The ligand is at 5' with a stop, and the receptor at 3' with another stop. The Cre used is SOX10-Cre, which can only recognize loxP. So the ligand's stop (loxP) is excised, allowing mCherry (if it's downstream in frame) to be expressed. But the receptor's stop is lox2272, which isn't recognized by the Cre, so the eGFP isn't expressed. Thus, no green signal.

So the eGFP isn't expressed because the stop isn't removed. But why? Because the Cre can't recognize lox2272. So the issue is that the lox sites are different and Cre can't cut them.

But the options don't state this. Therefore, perhaps the correct answer is D: the receptor and eGFP are not in frame. But I'm not confident.


--- Final Answer Content ---


The question involves a bicistronic vector expressing a ligand and receptor, with fluorescent markers (mCherry and eGFP) fused downstream of each ORF. The ligand is under the CBA promoter, and the receptor is under an IRES element. Between the ligand ORF and mCherry is a loxP-stop-loxP cassette, and between the receptor ORF and eGFP is a lox2272-stop-lox2272 cassette. The vector is designed to allow expression of mCherry upon excision of the loxP stop cassette and eGFP upon excision of the lox2272 stop cassette, both mediated by Cre recombinase.

When the mouse model homozygous for the construct is crossed with SOX10-Cre hemizygous mice, Cre is expressed in neural crest cells. However, no green signal (eGFP) is observed under confocal microscopy. The key issue lies in the fact that SOX10-Cre likely cannot recognize the lox2272 stop cassette, as lox2272 is a variant site that requires a specialized Cre variant. Without excision of the lox2272 stop cassette, the eGFP is not expressed, resulting in the absence of the green signal.

Analyzing the options:

- **A) Ligand and receptor are in a paracrine relationship**: This describes the functional interaction between the ligand and receptor but does not explain the lack of eGFP expression. Irrelevant to the issue.
  
- **B) The receptor-eGFP construct is stuck in the Golgi**: If the receptor-eGFP were improperly trafficked, it would still be detected in a Western blot. Since the blot shows proper expression, this is unlikely.

- **C) The enhancer for the ligand and receptor expression is missing**: The CBA promoter is a strong constitutive promoter, and the IRES element ensures receptor expression. There is no evidence of a missing enhancer in the construct design.

- **D) The receptor and eGFP are not in frame**: If the receptor and eGFP were out of frame, eGFP would not be expressed. However, the construct is designed to place the ORFs in frame. The lack of eGFP expression is more likely due to the failure of Cre to excise the lox2272 stop cassette.

The most plausible explanation is that the SOX10-Cre cannot recognize the lox2272 stop cassette, preventing eGFP expression. While none of the options explicitly address this, the closest explanation is **D**, as it accounts for the failure of eGFP expression due to a lack of proper ORF alignment, which could indirectly result from the stop cassette remaining intact.

Answer: D